Schedule 13G ownership disclosure
CYMABAY THERAPEUTICS INC
Security class unavailable · CUSIP: 23257D103
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,368,557
- Percent of class
- 9.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-15-000602
- Form type
- SC 13G
- Filer
- CymaBay Therapeutics, Inc.
- CIK
- CIK 1042074
- Filed
- Feb 11, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership